Related Experiment Video
Updated: Sep 4, 2025

03:58
Author Spotlight: Revolutionizing Microfluidics Through Microchannel Fabrication on Nanopaper
Published on: October 6, 2023
1.8K
Microfluidic Paper-Based Preconcentration and Retrieval for Rapid Ribonucleic Acid Biomarker Detection and
Yannan Yu1, Fengya Fan2, Zachary J Smith1
1Key Laboratory of Scientific Instrumentation of Anhui Higher Education Institutes, Department of Precision Machinery and Precision Instrumentation, University of Science and Technology of China, 96 JinZhai Road, Hefei 230026, China.
Analytical Chemistry
|July 20, 2022
Summary
This study introduces a 3D microfluidic paper-based analytical device (μPAD) preconcentrator for point-of-care diagnostics. It significantly enhances the limit of detection for low-abundance targets by concentrating samples effectively.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Point-of-Care Diagnostics
Background:
- Microfluidic paper-based analytical devices (μPADs) are crucial for point-of-care (POC) diagnostics.
- Paper's heterogeneity can limit the detection of low-abundance targets.
- On-site sample preconcentration is a viable strategy to overcome detection limits.
Purpose of the Study:
- To develop a 3D μPADs preconcentrator (3D-μP²).
- To enhance the limit of detection (LOD) of downstream assays.
- To demonstrate the device's application in sample concentration for POC diagnostics.
Main Methods:
- Development of a 3D-μP² device with stacked absorbent pads and an ion-selective membrane (PEDOT:PSS).
- Utilized electrokinetic trapping for sample preconcentration.
- Validated the device with a colorimetric assay for a single-stranded DNA target.
Main Results:
- Achieved up to 170-fold concentration of DNA targets in 80 seconds.
- Increased the LOD of the colorimetric assay by 3 orders of magnitude.
- Demonstrated a portable and cost-effective preconcentration method.
Conclusions:
- The 3D-μP² effectively increases sample concentration for improved assay sensitivity.
- This device offers a powerful solution for sample pretreatment in resource-limited POC settings.
- The technology has the potential to advance accessible diagnostics.

